Melanie Ricke-Hoch is a research scientist and the leader of the Molecular Cardiology research group at the Department of Cardiology and Angiology, Hannover Medical School in Hannover, Germany. The group's focus is on elucidating the pathomechanisms and genetic causes that can lead to the onset of heart failure, and specifically peripartum cardiomyopathy (PPCM), as well as analyzing the cardiotoxicity of anti-cancer therapies using human registry data sets and blood samples, cell culture models, and preclinical mouse models. These findings are used to further develop biomarkers for diagnostics and new therapeutic approaches through translational research.
